US$ 20.85
glp-1 news today cardiovascular outcomes 2025 november Pipeline Update: - Prime Therapeutics Cardiovascular disease continuum-GLP-1 action. Adapted
Description
Several RCTs including SAVORTIMI 53 (saxagliptin) [52], EXAMINE (alogliptin) [53], and TECOS (sitagliptin) [54] have shown that DPP4 inhibitors did not significantly reduce stroke risk [1]

GLP-1 Nutrition The GLP-1 Grocery List: What to Buy, Skip, and How to Save TLDR: All you need to know TLDR: Your pre-GLP-1 grocery list doesnt work anymore

Most readers took the wrong lesson from it
As a medical practice, we often encounter patients who struggle with managing their diabetes and maintaining a healthy weight

N Engl J Med (2016) 375:183444

Enhanced GIP secretion in obesity is associated with biochemical alteration and miRNA contribution to the development of liver steatosis
